It is a pharma private limited company based in New Delhi, Delhi, India, established in 2015.
2015 | New Delhi, Delhi, India | Struck OffCordelia Pharmaceutical Private Limited, a struck off private limited company, was established on 23 February 2015 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51101DL2015PTC277079. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Rabindra Kumar Verma (Director), Shushant Kumar (Director), Sonal Anil Jeswal (Director). Past directors included Firdousi. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at B14, Jawahar Mohalla, Lane No 10, Shashi Garden Mayur Vihar Phase I, New Delhi, Delhi, 110091.
U51101DL2015PTC277079
277079
23 February 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Cordelia Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rabindra Kumar Verma | Director | 06 Nov 2017 | Current |
| Shushant Kumar | Director | 23 Feb 2015 | Current |
| Sonal Anil Jeswal | Director | 23 Feb 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cordelia Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Cordelia Pharmaceutical had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cordelia Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cordelia Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cordelia Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rabindra Kumar Verma was appointed as a Director was appointed as a Director on 06 Nov 2017 & has been associated with this company since 8 years 1 month . was completed.
Progress on Cordelia Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was documented.
Cordelia Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi. was recorded as a recent event.
The activity Shushant Kumar was appointed as a Director was appointed as a Director on 23 Feb 2015 & has been associated with this company since 10 years 10 months . was completed.
Shushant Kumar was appointed as a Manager was appointed as a Manager on 23 Feb 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.
The activity Sonal Anil Jeswal was appointed as a Director was appointed as a Director on 23 Feb 2015 & has been associated with this company since 10 years 10 months . was completed.
The CIN of Cordelia Pharmaceutical Private Limited is U51101DL2015PTC277079.
Cordelia Pharmaceutical Private Limited is headquartered at B14, Jawahar Mohalla, Lane No 10, Shashi Garden Mayur Vihar Phase I, New Delhi, Delhi, 110091.
Cordelia Pharmaceutical Private Limited was incorporated on 23 February 2015.
The current directors of Cordelia Pharmaceutical Private Limited are
The primary industry of Cordelia Pharmaceutical Private Limited is Manufacturing.
Cordelia Pharmaceutical Private Limited is unlisted.
The authorized capital of Cordelia Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Cordelia Pharmaceutical Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX